Helix BioMedix, Inc. (HXBM)
OTCMKTS
· Delayed Price · Currency is USD
7.18
-0.01 (-0.14%)
At close: Mar 5, 2025
Helix BioMedix Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | 2002 - 2006 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '12 Sep 30, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 | Dec '07 Dec 31, 2007 | 2002 - 2006 |
Cash & Equivalents | 0.22 | 1.69 | 4.04 | 1.34 | 1.95 | 0.46 | Upgrade
|
Short-Term Investments | - | - | - | - | - | 0.7 | Upgrade
|
Cash & Short-Term Investments | 0.22 | 1.69 | 4.04 | 1.34 | 1.95 | 1.16 | Upgrade
|
Cash Growth | -89.53% | -58.24% | 200.76% | -31.21% | 68.33% | -48.55% | Upgrade
|
Receivables | 0.4 | 0.44 | 0.29 | 0.06 | 0.05 | 0.08 | Upgrade
|
Inventory | 0.33 | 0.36 | 0.28 | 0.2 | 0.11 | 0.07 | Upgrade
|
Prepaid Expenses | 0.06 | 0.06 | 0.06 | 0.03 | 0.1 | 0.14 | Upgrade
|
Total Current Assets | 1.21 | 2.56 | 4.67 | 1.64 | 2.22 | 1.45 | Upgrade
|
Property, Plant & Equipment | 0.02 | 0.03 | 0.04 | 0.08 | 0.12 | 0.13 | Upgrade
|
Long-Term Investments | 0.22 | 0.22 | 0.27 | - | - | - | Upgrade
|
Other Intangible Assets | 0.1 | 0.15 | 0.21 | 0.28 | 0.35 | 0.43 | Upgrade
|
Other Long-Term Assets | 0.01 | 0.02 | 0.03 | 0.01 | 0.01 | 0.01 | Upgrade
|
Total Assets | 1.7 | 2.97 | 5.23 | 2.01 | 2.7 | 2.02 | Upgrade
|
Accounts Payable | 0.32 | 0.13 | 0.13 | 0.07 | 0.07 | 0.1 | Upgrade
|
Accrued Expenses | 0.13 | 0.14 | 0.13 | 0.08 | 0.16 | 0.12 | Upgrade
|
Short-Term Debt | - | - | - | - | 0.97 | - | Upgrade
|
Current Unearned Revenue | 0.07 | 0.13 | 0.05 | - | - | 0.13 | Upgrade
|
Other Current Liabilities | - | 0.01 | 0 | - | 0 | - | Upgrade
|
Total Current Liabilities | 0.52 | 0.41 | 0.32 | 0.14 | 1.21 | 0.35 | Upgrade
|
Long-Term Debt | - | - | - | 6.34 | 3 | - | Upgrade
|
Other Long-Term Liabilities | 0.03 | 0.03 | 0.04 | 0.7 | 0.21 | 0 | Upgrade
|
Total Liabilities | 0.55 | 0.44 | 0.35 | 7.18 | 4.42 | 0.35 | Upgrade
|
Common Stock | 0.05 | 0.05 | 0.05 | 0.03 | 0.03 | 0.03 | Upgrade
|
Additional Paid-In Capital | 49.19 | 48.54 | 48.39 | 30.66 | 30.34 | 29.21 | Upgrade
|
Retained Earnings | -48.09 | -46.06 | -43.57 | -35.86 | -32.08 | -27.57 | Upgrade
|
Shareholders' Equity | 1.15 | 2.54 | 4.87 | -5.17 | -1.71 | 1.67 | Upgrade
|
Total Liabilities & Equity | 1.7 | 2.97 | 5.23 | 2.01 | 2.7 | 2.02 | Upgrade
|
Total Debt | - | - | - | 6.34 | 3.97 | - | Upgrade
|
Net Cash (Debt) | 0.22 | 1.69 | 4.04 | -4.99 | -2.02 | 1.16 | Upgrade
|
Net Cash Growth | -89.53% | -58.24% | - | - | - | -48.55% | Upgrade
|
Net Cash Per Share | 1.31 | 10.19 | 44.73 | -58.37 | -23.57 | 13.86 | Upgrade
|
Filing Date Shares Outstanding | 0.17 | 0.17 | 0.17 | 0.09 | 0.09 | 0.09 | Upgrade
|
Total Common Shares Outstanding | 0.17 | 0.17 | 0.17 | 0.09 | 0.09 | 0.09 | Upgrade
|
Working Capital | 0.69 | 2.15 | 4.36 | 1.5 | 1.01 | 1.11 | Upgrade
|
Book Value Per Share | 6.94 | 15.30 | 29.41 | -60.44 | -20.05 | 19.54 | Upgrade
|
Tangible Book Value | 1.05 | 2.39 | 4.66 | -5.45 | -2.07 | 1.24 | Upgrade
|
Tangible Book Value Per Share | 6.36 | 14.41 | 28.12 | -63.74 | -24.19 | 14.48 | Upgrade
|
Machinery | 0.57 | 0.57 | 0.63 | 0.62 | 0.6 | 0.59 | Upgrade
|
Leasehold Improvements | 0.01 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.